Rossi, Dario
 Distribuzione geografica
Continente #
NA - Nord America 431
EU - Europa 338
AS - Asia 72
AF - Africa 1
Totale 842
Nazione #
US - Stati Uniti d'America 429
SE - Svezia 126
IT - Italia 57
CN - Cina 46
UA - Ucraina 40
FR - Francia 34
DE - Germania 31
IE - Irlanda 31
IN - India 7
FI - Finlandia 6
RU - Federazione Russa 6
TR - Turchia 6
KR - Corea 4
GB - Regno Unito 3
IR - Iran 3
AT - Austria 2
HK - Hong Kong 2
CA - Canada 1
IL - Israele 1
JP - Giappone 1
LT - Lituania 1
MX - Messico 1
MY - Malesia 1
PL - Polonia 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 842
Città #
Chandler 125
Ashburn 40
New York 30
Dublin 25
Jacksonville 23
San Mateo 18
Marseille 14
Florence 12
Nanjing 11
Wilmington 9
Milan 8
Princeton 8
Beijing 7
Boston 7
Dearborn 7
Zhengzhou 7
Ann Arbor 6
Lawrence 6
Los Angeles 6
Munich 6
Shenyang 6
Redwood City 5
Izmir 4
Nanchang 4
Norwalk 4
Rome 4
Seattle 4
Seoul 4
University Park 4
Vicopisano 4
Cattolica 3
Fairfield 3
Falls Church 3
Fremont 3
Pune 3
Woodbridge 3
Bruino 2
Burdur 2
Garden City 2
Hong Kong 2
Houston 2
Jiaxing 2
Kish 2
Kunming 2
Nave 2
Turin 2
Verona 2
Vienna 2
Washington 2
Andover 1
Boardman 1
Bremen 1
Busto Arsizio 1
Cambridge 1
Changchun 1
Changsha 1
Gurgaon 1
Hangzhou 1
Hanoi 1
Hanover 1
Hebei 1
Hefei 1
Johannesburg 1
Las Vegas 1
Leawood 1
Mountain View 1
Parma 1
Phoenix 1
Pomigliano D'arco 1
Putrajaya 1
Sacramento 1
Saint Petersburg 1
San Giovanni Teatino 1
Tianjin 1
Toronto 1
Warsaw 1
Wuhan 1
Totale 490
Nome #
Ereditabilità delle caratteristiche del bulbo dell'aglio ( Allium sativum L.) " Bianco piacentino. 79
Spread of herbicide resistant weedy rice (red rice, Oryza sativa L.) after five years of Clearfield rice cultivation in Italy 78
Fluorescent-AFLP analysia of garlic germoplasm. 77
Phylogenetics relationship in the genus Nicotiana assessed by means of AFLPs. 68
Metagenomics analysis of microbiota from fermented sausages before ripening 65
Fluorescent microsatelite markers analysis for Rice cultivar characterization and description. 62
Assessment of the 4-factor score: Retrospective analysis of 586 CLL patients receiving ibrutinib. A campus CLL study 56
Comparison of ibrutinib and idelalisib plus rituximab in real-life relapsed/resistant chronic lymphocytic leukemia cases 55
Survival risk score for real-life relapsed/refractory chronic lymphocytic leukemia patients receiving ibrutinib. A campus CLL study 50
Sometimes they come back: New and old spinal muscular atrophy adults in the era of nusinersen 49
CD49d promotes disease progression in chronic lymphocytic leukemia: New insights from CD49d bimodal expression 43
Effectiveness of ibrutinib as first-line therapy for chronic lymphocytic leukemia patients and indirect comparison with rituximab-bendamustine: Results of study on 486 cases outside clinical trials 38
TP53 disruption as a risk factor in the era of targeted therapies: A multicenter retrospective study of 525 chronic lymphocytic leukemia cases 36
COVID-19 severity and mortality in patients with chronic lymphocytic leukemia: a joint study by ERIC, the European Research Initiative on CLL, and CLL Campus 28
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia 19
Ibrutinib dose intensity in high-risk chronic lymphocytic leukemia 19
The time to first treatment is an independent predictor of overall survival in chronic lymphocytic leukemia 18
Efficacy of front-line ibrutinib versus fludarabine, cyclophosphamide, and rituximab in patients with chronic lymphocytic leukemia: A retrospective multicenter “Real-World” study 13
Caregivers’ Expectations on Possible Functional Changes following Disease-Modifying Treatment in Type II and III Spinal Muscular Atrophy: A Comparative Study 3
Totale 856
Categoria #
all - tutte 3.818
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 3.818


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 6 1
2019/202065 17 1 5 0 1 2 9 3 8 3 10 6
2020/202152 1 6 0 7 7 3 6 4 7 1 9 1
2021/2022166 8 6 25 21 24 3 2 19 4 2 37 15
2022/2023305 41 48 14 46 19 40 18 22 38 0 12 7
2023/2024171 9 42 13 17 8 49 8 8 4 13 0 0
Totale 856